References
- Pawelczyk M, van Laer L, Fransen E, Rajkowska E, Konings A, Carlsson PI, . Analysis of gene polymorphisms associated with K ion circulation in the inner ear of patients susceptible and resistant to noise induced hearing loss. Ann Hum Genet. 2009; 73:411–21.
- Konings A, van Laer L, Wiktorek-Smagur A, Rajkowska E, Pawelczyk M, Carlsson PI, . Candidate gene association study for noise induced hearing loss in two independent noise exposed populations. Ann Hum Genet. 2009; 73:215–24.
- Friedman RA, van Laer L, Huentelman MJ, Sheth SS, van Eyken E, Corneveaux JJ, . GRM7 variants confer susceptibility to age related hearing impairment. Hum Mol Genet. 2009; 18:785–96.
- Dawood S. Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ‘p's of individualized therapy. Cancer Invest. 2009; 27:809–15.
- Marín F, González-Conejero R, Capranzano P, Bass TA, Roldán V, Angiolillo DJ. Pharmacogenetics in cardiovascular anti-thrombotic therapy. J Am Coll Cardiol. 2009; 54:1041–57.
- Schosser A, Kasper S. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol. 2009; Sep 4 (Epub ahead of print).
- Carey L. Pharmacogenetics: what PAs need to understand and why. J Am Acad Phys Assit. 2009; 22:61–2.
- Sandanaraj E, Lal S, Cheung YB, Xiang X, Kong MC, Lee LH, . VKORC1 diplotype-derived dosing model to explain variability in warfarin dose requirements in Asian patients. Drug Metab Pharmacokinet. 2009; 24:365–75.
- Skinner HG, Gangnon R, Boardman LA. Using biomarkers of ageing to identify modifiable mechanisms underlying age related risk for cancer. WMJ. 2009; 108:280–1.
- Qiu FM, Yu JK, Chen YD, Jin QF, Sui MH, Huang J. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. J Exp Clin Cancer Res. 2009; 28:126–30.
- Chavez JC, Hurko O, Barone FC, Feuerstein GZ. Pharmacologic interventions for stroke. Looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke. 2009; 40:558–63.
- Podbielska M, Hogan E. Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?. Mult Scler. 2009; 15:1011–29.
- Vambutas A, DeVoti J, Goldofsky E, Gordon M, Lesser M, Bonagura V. Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One. 2009; 4:5293–8.
- Capaccio P, Cuccarini V, Ottaviani F, Fracchiolla NS, Bossi A, Pignataro L. Prothrombotic gene mutations in patients with sudden sensorineural hearing loss and cardiovascular thrombotic disease. Ann Otol Rhinol Laryngol. 2009; 118:205–10.
- Mulcahy E. Managing disease with nanomedicine. Nano. 2009; 11:4–5.
- Zhang L, Webster TJ. Nanotechnology and nanomaterials: promises for improved tissue regeneration. NatoToday. 2008; 10:14–7.
- Webster TJ, Jin S. Regenerate: nanomaterials for building body parts. Nano. 2009; 11:14–7.
- Kesser BW, Lalwani AK. Gene therapy and stem cell transplantation: strategies for hearing restoration. Adv Otorhinolaryngol. 2009; 66:64–86.
- Zou J, Poe D, Bjelke B, Pyykko I. Visualization of inner ear disorders with MRI in vivo: from animal models to human application. Acta Otolaryngol Suppl. 2009; 560:22–31.
- Zou J, Saulnier P, Perrier T, Zhang Y, Manninen T, Toppila E, Pyykkö I. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J Biomed Mater Res B Appl Biomater. 2008; 87:10–8.
- Cheper V, Wolf M, Scholl M, Kadlecova Z, Perrier T, Klok HA, . Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomed. 2009; 4:623–35.